Literature DB >> 27548652

Aberrant immune response with consequent vascular and connective tissue remodeling - causal to scleroderma and associated syndromes such as Raynaud phenomenon and other fibrosing syndromes?

Nedim Durmus1, Sung-Hyun Park, Joan Reibman, Gabriele Grunig.   

Abstract

PURPOSE OF REVIEW: Scleroderma and other autoimmune-induced connective tissue diseases are characterized by dysfunctions in the immune system, connective tissue and the vasculature. We are focusing on systemic sclerosis (SSc)-associated pulmonary hypertension, which remains a leading cause of death with only a 50-60% of 2-year survival rate. RECENT
FINDINGS: Much research and translational efforts have been directed at understanding the immune response that causes SSc and the networked interactions with the connective tissue and the vasculature. One of the unexpected findings was that in some cases the pathogenic immune response in SSc resembles the immune response to helminth parasites. During coevolution, means of communication were developed which protect the host from over-colonization with parasites and which protect the parasite from excessive host responses. One explanation for the geographically clustered occurrence of SSc is that environmental exposures combined with genetic predisposition turn on triggers of molecular and cellular modules that were once initiated by parasites.
SUMMARY: Future research is needed to further understand the parasite-derived signals that dampen the host response. Therapeutic helminth infection or treatment with parasite-derived response modifiers could be promising new management tools for autoimmune connective tissue diseases.

Entities:  

Mesh:

Year:  2016        PMID: 27548652      PMCID: PMC5114306          DOI: 10.1097/BOR.0000000000000333

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  80 in total

1.  Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis.

Authors:  Eguzkine Ochoa; José-Ezequiel Martin; Shervin Assasi; Lorenzo Beretta; Patricia Carreira; Alfredo Guillén; Carmen Pilar Simeón; Eugénie Koumakis; Philippe Dieude; Yannick Allanore; Francisco J García-Hernández; Gerard Espinosa; Ivan Castellví; Jose Luis Trapiella; Luis Rodriguez; Miguel Ángel González-Gay; María Victoria Egurbide; Luis Sáez; Jose Luis Callejas-Rubio; Jose Antonio Vargas-Hitos; Nicolas Hunzelmann; Gabriela Riemekasten; Torsten Witte; Jörg H W Distler; Alexander Kreuter; Claudio Lunardi; Alessandro Santaniello; Filemon K Tan; Paul G Shiels; Ariane Herrick; Jane Worthington; Madelon C Vonk; Bobby P Koeleman; Timothy R D J Radstake; Maureen D Mayes; Javier Martin
Journal:  Clin Exp Rheumatol       Date:  2015-08-27       Impact factor: 4.473

2.  Allergic host defences.

Authors:  Noah W Palm; Rachel K Rosenstein; Ruslan Medzhitov
Journal:  Nature       Date:  2012-04-25       Impact factor: 49.962

3.  Association of occupational exposure with features of systemic sclerosis.

Authors:  Isabelle Marie; Jean-François Menard; Anne-Bénédicte Duval-Modeste; Pascal Joly; Stéphane Dominique; Pierre Bravard; David Noël; Jean-François Gehanno; Michael Bubenheim; Jacques Benichou; Hervé Levesque
Journal:  J Am Acad Dermatol       Date:  2015-01-10       Impact factor: 11.527

4.  Transforming growth factor-β signaling promotes pulmonary hypertension caused by Schistosoma mansoni.

Authors:  Brian B Graham; Jacob Chabon; Liya Gebreab; Jennifer Poole; Elias Debella; Laura Davis; Takeshi Tanaka; Linda Sanders; Nina Dropcho; Angela Bandeira; R William Vandivier; Hunter C Champion; Ghazwan Butrous; Xiao-Jing Wang; Thomas A Wynn; Rubin M Tuder
Journal:  Circulation       Date:  2013-08-19       Impact factor: 29.690

5.  Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  Romy B Christmann; Everett Hayes; Sarah Pendergrass; Cristina Padilla; Giuseppina Farina; Alsya J Affandi; Michael L Whitfield; Harrison W Farber; Robert Lafyatis
Journal:  Arthritis Rheum       Date:  2011-06

6.  Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.

Authors:  Anthony J Tyndall; Bettina Bannert; Madelon Vonk; Paolo Airò; Franco Cozzi; Patricia E Carreira; Dominique Farge Bancel; Yannick Allanore; Ulf Müller-Ladner; Oliver Distler; Florenzo Iannone; Raffaele Pellerito; Margarita Pileckyte; Irene Miniati; Lidia Ananieva; Alexandra Balbir Gurman; Nemanja Damjanov; Adelheid Mueller; Gabriele Valentini; Gabriela Riemekasten; Mohammed Tikly; Laura Hummers; Maria J S Henriques; Paola Caramaschi; Agneta Scheja; Blaz Rozman; Evelien Ton; Gábor Kumánovics; Bernard Coleiro; Eva Feierl; Gabriella Szucs; Carlos Alberto Von Mühlen; Valeria Riccieri; Srdan Novak; Carlo Chizzolini; Anna Kotulska; Christopher Denton; Paulo C Coelho; Ina Kötter; Ismail Simsek; Paloma García de la Pena Lefebvre; Eric Hachulla; James R Seibold; Simona Rednic; Jirí Stork; Jadranka Morovic-Vergles; Ulrich A Walker
Journal:  Ann Rheum Dis       Date:  2010-06-15       Impact factor: 19.103

7.  Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors.

Authors:  C S Potten; G Owen; D Hewitt; C A Chadwick; H Hendry; B I Lord; L B Woolford
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

Review 8.  Vascular hypothesis revisited: Role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis.

Authors:  Otavio Cabral-Marques; Gabriela Riemekasten
Journal:  Autoimmun Rev       Date:  2016-03-10       Impact factor: 9.754

9.  Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis.

Authors:  Patrizia Fuschiotti; Adriana T Larregina; Johnan Ho; Carol Feghali-Bostwick; Thomas A Medsger
Journal:  Arthritis Rheum       Date:  2013-01

10.  Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry.

Authors:  Lorinda Chung; Harrison W Farber; Raymond Benza; Dave P Miller; Lori Parsons; Paul M Hassoun; Michael McGoon; Mark R Nicolls; Roham T Zamanian
Journal:  Chest       Date:  2014-12       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.